Michael Rink MD, FEBU

Prof. Dr. Michael Rink, MD, FEBU, is a Professor of Urology, at the University Medical Center Hamburg-Eppendorf (UKE) in Hamburg, Germany. He is a national and European board-certified urologist who has major expertise and experience in treating genitourinary cancers. He is head of the Bladder and Renal Cell Carcinoma Section at the Urological Department and coordinator of the Uro-oncologic Comprehensive Cancer Center. In addition, he is a consultant urologist at the Martini Clinic and Prostate Cancer Center at UKE in Hamburg. Prof. Dr. Rink is focused on the research of fundamental biological and prognostic markers as well as translational outcomes in urothelial and renal cell carcinoma. He participated in several national and international clinical trials as a principal- or sub-investigator and is involved in numerous multi-institutional clinical research studies. He is also a member of several national and international scientific societies and sits on the boards of some non-profit societies. He is a panel member of the EAU muscle-invasive bladder cancer guideline.